Incorporation of noninvasive assessments in risk prediction for pulmonary arterial hypertension

por Quan, Ruilin, Chen, Xiaoxi, Yang, Tao, Li, Wen, Qian, Yuling, Lin, Yangyi, Xiong, Changming, Shan, Guangliang, Gu, Qing, He, Jianguo
Publicado 2022

Clinical features and long-term survival in idiopathic pulmonary arterial hypertension with thyroid dysfunction: insights from a national multicentre prospective study

por Qian, Yuling, Quan, Ruilin, Chen, Xiaoxi, Zhang, Gangcheng, Yang, Yuanhua, Chen, Yucheng, Yu, Zaixin, Gu, Qing, Xiong, Changming, Han, Huijun, He, Jianguo
Publicado 2023

The prevalence and survival of pulmonary hypertension due to left heart failure: A retrospective analysis of a multicenter prospective cohort study

por Lin, Yangyi, Pang, Lingpin, Huang, Shian, Shen, Jieyan, Wu, Weifeng, Tang, Fangming, Su, Weiqing, Zhu, Xiulong, Sun, Jingzhi, Quan, Ruilin, Yang, Tao, Han, Huijun, He, Jianguo
Publicado 2022

Impact of borderline pulmonary hypertension due to left heart failure on mortality in a multicenter registry study: A 3-year survivorship analysis

por Lin, Yangyi, Pang, Lingpin, Huang, Shian, Shen, Jieyan, Wu, Weifeng, Tang, Fangming, Su, Weiqing, Zhu, Xiulong, Sun, Jingzhi, Quan, Ruilin, Yang, Tao, Han, Huijun, He, Jianguo
Publicado 2022

Risk prediction in pulmonary hypertension due to chronic heart failure: incremental prognostic value of pulmonary hemodynamics

por Quan, Ruilin, Huang, Shian, Pang, Lingpin, Shen, Jieyan, Wu, Weifeng, Tang, Fangming, Zhu, Xiulong, Su, Weiqing, Sun, Jingzhi, Yu, Zaixin, Wang, Lemin, Zhu, Xianyang, Xiong, Changming, He, Jianguo
Publicado 2022

10-year survival of pulmonary arterial hypertension associated with connective tissue disease: insights from a multicentre PAH registry

por Chen, Xiaoxi, Quan, Ruilin, Qian, Yuling, Yang, Zhenwen, Yu, Zaixin, Zhang, Caojin, Yang, Yuanhua, Zhang, Gangcheng, Shen, Jieyan, Wang, Qian, Gu, Qing, Xiong, Changming, Jing, Xiaoli, Han, Huijun, He, Jianguo
Publicado 2023

Prevalence, risk factors, and survival associated with pulmonary hypertension and heart failure among patients with underlying coronary artery disease: a national prospective, mult...

por Huang, Li, Pang, Lingpin, Gu, Qing, Yang, Tao, Li, Wen, Quan, Ruilin, Su, Weiqing, Wu, Weifeng, Tang, Fangming, Zhu, Xiulong, Shen, Jieyan, Sun, Jingzhi, Shan, Guangliang, Xiong, Changming, Huang, Shian, He, Jianguo
Publicado 2022

Risk prediction in medically treated chronic thromboembolic pulmonary hypertension

por Quan, Ruilin, Yang, Yuanhua, Yang, Zhenwen, Tian, Hongyan, Li, Shengqing, Shen, Jieyan, Ji, Yingqun, Zhang, Gangcheng, Zhang, Caojin, Wang, Guangyi, Liu, Yuhao, Cheng, Zhaozhong, Yu, Zaixin, Song, Zhiyuan, Zheng, Zeqi, Cui, Wei, Chen, Yucheng, Liu, Shuang, Chen, Xiaoxi, Qian, Yuling, Xiong, Changming, Shan, Guangliang, He, Jianguo
Publicado 2021

Supplementation with Iron in Pulmonary Arterial Hypertension. Two Randomized Crossover Trials

por Howard, Luke S. G. E., He, Jianguo, Watson, Geoffrey M. J., Huang, Li, Wharton, John, Luo, Qin, Kiely, David G., Condliffe, Robin, Pepke-Zaba, Joanna, Morrell, Nicholas W., Sheares, Karen K., Ulrich, Anna, Quan, Ruilin, Zhao, Zhihui, Jing, Xiaoli, An, Chenhong, Liu, Zhihong, Xiong, Changming, Robbins, Peter A., Dawes, Timothy, de Marvao, Antonio, Rhodes, Christopher J., Richter, Manuel J., Gall, Henning, Ghofrani, Hossein A., Zhao, Lan, Huson, Les, Wilkins, Martin R.
Publicado 2021